Cargando…

Treating neglected tropical diseases

Detalles Bibliográficos
Autor principal:	Hopkins, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Centre for Eye Health 2013
Materias:	Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756644/ https://www.ncbi.nlm.nih.gov/pubmed/24023399

Ejemplares similares

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Treating ROP: how and when
por: Quinn, Graham, et al.
Publicado: (2017)

Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study
por: Barbulescu, Andrei, et al.
Publicado: (2020)

Cardiac Sarcoidosis: When and How to Treat Inflammation
por: Giblin, Gerard T, et al.
Publicado: (2021)

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
por: Liang, Huifang, et al.
Publicado: (2019)

To end the neglect of neglected tropical diseases
por: The Lancet Regional Health – Western Pacific
Publicado: (2022)

Social sciences research in neglected tropical diseases 1: the ongoing neglect in the neglected tropical diseases
por: Allotey, Pascale, et al.
Publicado: (2010)

Neglected Tropical Diseases outside the Tropics
por: Norman, Francesca F., et al.
Publicado: (2010)

Neglected tropical diseases
por: Molyneux, David
Publicado: (2013)

Neglected tropical diseases
por: Parija, Subhash Chandra
Publicado: (2022)

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
por: Christensen, Ingrid Egeland, et al.
Publicado: (2022)

Ending the “Neglect” to End Neglected Tropical Diseases
por: Yang, Pin, et al.
Publicado: (2022)

Neglected Testing for Neglected Tropical Diseases at the CDC
por: Beatty, Norman L., et al.
Publicado: (2022)

Neglected Tropical Diseases, Neglected Data Sources, and Neglected Issues
por: Singer, Burton H., et al.
Publicado: (2007)

Pneumococcal vaccination in autoimmune rheumatic diseases
por: Rákóczi, Éva, et al.
Publicado: (2017)

Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine
por: Lems, Willem, et al.
Publicado: (2021)

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
por: Russell, Mark D, et al.
Publicado: (2023)

Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis
por: Gehin, Johanna Elin, et al.
Publicado: (2021)

India’s neglected tropical diseases
por: Hotez, Peter J., et al.
Publicado: (2018)

Neglected Tropical Diseases in Lebanon
por: Alam, Walid, et al.
Publicado: (2022)

Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews
por: Rodriguez-García, Sebastián Cruz, et al.
Publicado: (2021)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Who Neglects Neglected Tropical Diseases? - Korean Perspective
por: Choi, Min-Ho, et al.
Publicado: (2015)

Why is noma a neglected-neglected tropical disease?
por: Srour, M. Leila, et al.
Publicado: (2020)

Neglected Tropical Diseases in Pakistan: A Story of Neglect
por: KHAN, Aisha, et al.
Publicado: (2020)

Nine-year follow-up of local implantation of autologous skeletal myoblasts in a patient with coronary heart disease
por: Zhang, Dingguo, et al.
Publicado: (2013)

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
por: Pitt, Bertram, et al.
Publicado: (2015)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview
por: Toussirot, Éric, et al.
Publicado: (2016)

Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases
por: Cheung, Michelle W, et al.
Publicado: (2022)

Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
por: Stajszczyk, Marcin, et al.
Publicado: (2023)

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre‐specified subgroup with heart failure
por: Rossignol, Patrick, et al.
Publicado: (2020)

Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation
por: Cederqvist, Sanna, et al.
Publicado: (2021)

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
por: van der Togt, Céleste J T, et al.
Publicado: (2023)

Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)
por: Perez-Garcia, Luis Fernando, et al.
Publicado: (2023)

Self-evidence-based digital care programme improves health-related quality of life in adults with a variety of autoimmune diseases and long COVID: a retrospective study
por: Bundy, Nicole, et al.
Publicado: (2023)

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation
por: Butink, Maarten H P, et al.
Publicado: (2023)

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
por: Curtis, Jeffrey R, et al.
Publicado: (2019)

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies
por: Reinisch, Walter, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s3v42dte8v6jv7d8j2r0nqf3do